The present invention relates to clotrimazole/quinoline hybrids useful as active ingredients of anti-malaria drugs. The compounds show a remarkable in vitro biological activity especially against the chloroquine-resistant
Plasmodium falciparum
strains and in vivo activity against
P. berghei.
本发明涉及
克霉唑/
喹啉杂合物,可作为抗疟疾药物的活性成分。这些化合物在体外显示出显著的
生物活性,特别是对
氯喹耐药恶性疟原虫株的活性,以及对伯氏恶性疟原虫的体内活性。